Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026.
- Largest single sale: $1.4M (10,800 shares) of Zoetis on Feb 17, 2026. Filing
- Last sale before this period: Feb 19, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Zoetis (ZTS) | Chief Executive Officer, Director | Feb 4, 2013 | Oct 13, 2026 |
| BlackRock (BLK) | Director | Oct 2, 2024 | Oct 2, 2026 |
| Pfizer (PFE) | Former Executive Vice President | Apr 7, 2010 | Nov 1, 2012 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 30, 2026, BlackRock: 30 shares awarded. 1 filing: 1
- Jun 30, 2026, BlackRock: 34 shares awarded. 1 filing: 1
- Mar 31, 2026, BlackRock: 34 shares awarded. 1 filing: 1
- Feb 19, 2026, Zoetis: 7,354 shares vested or acquired by exercising options; 3,623 shares withheld by the company for taxes. 1 filing: 1
- Feb 17, 2026, Zoetis: sold 20,000 shares for $2.5M, under a disclosed plan; 20,000 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.